Vericel Corp·4

Jan 9, 4:05 PM ET

Halpin Michael 4

4 · Vericel Corp · Filed Jan 9, 2026

Insider Transaction Report

Form 4
Period: 2026-01-07
Halpin Michael
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-07$16.66/sh+10,000$166,60026,080 total
  • Sale

    Common Stock

    2026-01-07$40.48/sh10,000$404,80016,080 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2026-01-07+10,00046,250 total
    Exercise: $16.66Exp: 2029-02-06Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024.
  • [F3]These options, representing the right to purchase 76,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4